# Alpha Cognition Inc. (ACOG) · Edgar & Edgarette company card

> Alpha Cognition (ACOG) reported revenue of $10 million in FY2025, operating margin -222% against a -15.8% median for biological products, (no diagnostic substances), equity 78.4% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1655923 · fiscal year ended 2025-12-31 · 1 audited years read · [page](https://www.pops4.com/boards/company/ACOG) · [JSON](https://www.pops4.com/boards/company/ACOG.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $10M |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | -221.7% |
| Net margin | -202.2% |
| Operating cash flow | −$20M |
| Capital spending | $293,489 |
| Free cash flow | −$21M |
| Cash | $66M |
| Long-term debt | — |
| Total assets | $80M |
| Total equity | $63M |
| Equity ÷ assets | 78.4% |
| Return on equity | -33.1% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 3.69 (safe zone)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative; operating loss: a margin of -221.7% in FY2025

## Edgarette's reading

Exposure: revenue $10.2M (FY2025). Experience: one year on record; operating margin -221.7%. Soundness: equity 78.4% of assets, return on equity -33.1%. Credibility: one audited year, little weight. Against peers (31 filers, $50M+ revenue, biological products, (no diagnostic substances)): operating margin -221.7% against a -15.8% median.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-11-12 ([filing](https://www.sec.gov/Archives/edgar/data/1655923/000121390026118958/0001213900-26-118958-index.htm))

## Recent filings

- 8-K · filed 2026-11-12 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1655923/000121390026118958/0001213900-26-118958-index.htm)
- 10-Q · filed 2026-11-12 · [filing](https://www.sec.gov/Archives/edgar/data/1655923/000121390026118702/0001213900-26-118702-index.htm)
- 10-Q · filed 2026-08-13 · [filing](https://www.sec.gov/Archives/edgar/data/1655923/000121390026089188/0001213900-26-089188-index.htm)
- 8-K · filed 2026-06-23 · 5.02 Departure or Election of Directors; Appointment of Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1655923/000121390026070903/0001213900-26-070903-index.htm)
- 10-Q · filed 2026-05-14 · [filing](https://www.sec.gov/Archives/edgar/data/1655923/000121390026056588/0001213900-26-056588-index.htm)
- DEF 14A · filed 2026-04-30 · [filing](https://www.sec.gov/Archives/edgar/data/1655923/000121390026050234/0001213900-26-050234-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001655923.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1655923

## Cite

POPS4, Edgar & Edgarette: Alpha Cognition Inc. (ACOG) company card, from the company's own SEC filings, accessed 2026-11-13, https://www.pops4.com/boards/company/ACOG. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.